作者:Fraser J. Scott、Mireia Puig-Sellart、Abedawn I. Khalaf、Catherine J. Henderson、Gareth Westrop、David G. Watson、Katharine Carter、M. Helen Grant、Colin J. Suckling
DOI:10.1016/j.bmcl.2016.06.040
日期:2016.8
activity by screening against the melanoma cancer cell line B16-F10. Five compounds have been found to possess significant activity, more so than a standard therapy, Gemcitabine. Moreover, one compound has been found to have an activity around 70-fold that of Gemcitabine and has a favourable selectivity index of greater than 125. Furthermore, initial studies have revealed this compound to be metabolically
通过针对黑素瘤癌细胞系B16-F10进行筛选,评估了一系列47种结构多样的MGB(源自天然产物双歧霉素)的抗肺癌活性。已经发现有五种化合物具有显着的活性,比标准疗法吉西他滨具有更多的活性。此外,已发现一种化合物的活性约为吉西他滨的70倍,且选择性指数大于125。此外,初步研究表明该化合物具有代谢稳定性,因此代表了进一步优化的先导寻求一种新型的肺癌治疗方法。